Drug Interactions and Side Effects of Aprotinin and Ramipril and Aspirin and Atenolol and Hydrochlorothiazide and Amlodipine and Etomidate and Midazolam Hydrochloride and Sufentanil Citrate and Vecuronium Bromide and Isoflurane and Clindamycin
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 174048 | Jul, 28, 2006 | 61 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Aprotinin | aprotinin bovine |
Ramipril | ramipril |
Aspirin | aspirin |
Atenolol | atenolol |
Hydrochlorothiazide | hydrochlorothiazide |
Amlodipine | amlodipine besylate |
Etomidate | etomidate |
Midazolam Hydrochloride | midazolam hydrochloride |
Sufentanil Citrate | sufentanil citrate |
Vecuronium Bromide | vecuronium bromide |
Isoflurane | isoflurane |
Clindamycin | clindamycin phosphate |
| Name |
Atrial Thrombosis |
Cardiac Procedure Complication |
Catheter Site Haemorrhage |
Condition Aggravated |
Deep Vein Thrombosis |
Disseminated Intravascular Coagulation |
Embolism Venous |
Hypotension |
Intracardiac Thrombus |
Operative Haemorrhage |
Pulmonary Artery Thrombosis |
Pulmonary Hypertension |
Vena Cava Thrombosis |
Venous Thrombosis |
Ventricular Failure |
Results from eHealthMe : 3 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Atrial Thrombosis | 1 (33.33%) |
Cardiac Procedure Complication | 2 (66.67%) |
Catheter Site Haemorrhage | 2 (66.67%) |
Condition Aggravated | 2 (66.67%) |
Deep Vein Thrombosis | 1 (33.33%) |
Disseminated Intravascular Coagulation | 3 (100.00%) |
Embolism Venous | 3 (100.00%) |
Hypotension | 3 (100.00%) |
Intracardiac Thrombus | 2 (66.67%) |
Operative Haemorrhage | 2 (66.67%) |
Pulmonary Artery Thrombosis | 2 (66.67%) |
Pulmonary Hypertension | 3 (100.00%) |
Vena Cava Thrombosis | 2 (66.67%) |
Venous Thrombosis | 3 (100.00%) |
Ventricular Failure | 2 (66.67%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Hypotension | 3 (100.00%) |
Embolism Venous | 3 (100.00%) |
Disseminated Intravascular Coagulation | 3 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports: